Drug – bio-affecting and body treating compositions – Effervescent or pressurized fluid containing – Organic pressurized fluid
Patent
1996-03-25
1997-04-08
Levy, Neil S.
Drug, bio-affecting and body treating compositions
Effervescent or pressurized fluid containing
Organic pressurized fluid
514568, 514570, A61K 912
Patent
active
056185162
ABSTRACT:
A hydrophile pharmaceutical composition in the form of foam is described which contains as active ingredient Ketoprofen lysine salt having a concentration between 10 and 20% p/volume of solution which allows, for topic treatment, the maximum absorption of the active principle. The foam is applied for the local treatment in painful and phlogistic conditions, of rheumatic or traumatic nature, of the articulations, of the musles, of the tendons and of the ligaments.
REFERENCES:
patent: 4282216 (1981-08-01), Rovee et al.
patent: 4593044 (1986-06-01), Metz
patent: 4954332 (1990-09-01), Bissett et al.
Abstract # CA99 (24): 200431X; Pharmacokinetics of a Slow-Release Preparation of Ketoprofen Lysine in Man; Borsa et al.
Ketoprofen Penetration into Suction Skin Blister Fluid: A Comparison of Two Topical Formulations of Ketoprofen Lysine; Advances in Therapy, vol. 10 No. 2 Mar./Apr. 1993; pp. 86-94.
Farmacocinetica Di Ketoprofene Sale Di Lisina Dopo Applicazione Percutanea Della Formulazione Schiuma: Risultati Sperimentali E Clinici; Faramci vol. 16 No. 9-10/'92; pp. 1-11.
Clavenna Gaetano
Poletti Giorgio
Domp e Farmaceutici SpA
Levy Neil S.
LandOfFree
Method of reducing subcutaneous inflammation by the topical appl does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of reducing subcutaneous inflammation by the topical appl, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of reducing subcutaneous inflammation by the topical appl will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2396331